PARTI Company Overview We are a late-stage clinical specialty pharmaceutical company focused on the development and commercialization of therapeutic products that treat rare and orphan diseases for which there are currently either no approved or very limited treatments or cures. Our lead product, QRX003, is under clinical development as a potential treatment for Netherton Syndrome (NS), a rare hereditary genetic disease. QRX003 is entering pivotal registrational clinical testing under an open In...
Q2 FY2026 — expected 2026-08-15
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-26 | 2025-12-31 | 0001104659-26-035251 | EDGAR | 81K words |
| 2025-03-13 | 2024-12-31 | 0001410578-25-000336 | EDGAR | — |
| 2024-03-14 | 2023-12-31 | 0001410578-24-000198 | EDGAR | — |
| 2023-03-15 | 2022-12-31 | 0001410578-23-000267 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-06 | 2025-09-30 | 0001104659-25-107785 | EDGAR | 20K words |
| 2025-08-07 | 2025-06-30 | 0001410578-25-001613 | EDGAR | — |
| 2025-05-13 | 2025-03-31 | 0001410578-25-001226 | EDGAR | — |
| 2024-11-08 | 2024-09-30 | 0001410578-24-001804 | EDGAR | — |
| 2024-08-08 | 2024-06-30 | 0001410578-24-001216 | EDGAR | — |
| 2024-05-09 | 2024-03-31 | 0001410578-24-000701 | EDGAR | — |
| 2023-11-09 | 2023-09-30 | 0001410578-23-002320 | EDGAR | — |
| 2023-08-03 | 2023-06-30 | 0001410578-23-001531 | EDGAR | — |
| 2023-05-09 | 2023-03-31 | 0001410578-23-000940 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-26 | 0001104659-26-034951 | EDGAR | 3K words |
| 2026-03-11 | 0001104659-26-026410 | EDGAR | — |
| 2026-01-20 | 0001104659-26-005127 | EDGAR | — |
| 2025-11-17 | 0001104659-25-113237 | EDGAR | — |
| 2025-11-12 | 0001104659-25-109802 | EDGAR | — |
| 2025-11-06 | 0001104659-25-107747 | EDGAR | — |
| 2025-10-21 | 0001104659-25-101269 | EDGAR | — |
| 2025-10-15 | 0001104659-25-099735 | EDGAR | — |
| 2025-08-27 | 0001104659-25-083248 | EDGAR | — |
| 2025-08-21 | 0001104659-25-081480 | EDGAR | — |
264 total filings indexed. 241 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001671502 |
| Ticker | QNRX |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | L3 |
| Website | https://www.quoinpharma.com |
| Listed | 2021-10-28 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/QNRX (~200 tokens, structured JSON with cryptographic provenance)